Novavax financial statements

노바백스NASDAQ:NVAX · Nasdaq · Healthcare · sector #17
$11.32-9.87%
2026-10-06 close

Novavax's published financial data is dated 2026-10-04. 2024 revenue was $682M. 2024 operating profit was −$249M.

Reported results

Novavax notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q